Table 3.
Side effect after receiving vaccines related to gender
| Symptoms |
After 1st dose of COVID-19 vaccineFrequency (%) |
p Value |
After 2nd dose of COVID-19 vaccineFrequency (%) |
p Value | ||
|---|---|---|---|---|---|---|
| Female N = 684 | Male N = 402 | Female N = 211 | Male N = 109 | |||
|
Presence No Yes |
53 (7.7) 631 (92.3) |
57 (14.2) 345(85.8) |
0.001 | 54(25.6)15 7 (74.4) |
18(16.5) 91 (83.5) |
0.065 |
|
Injection site pain Redness and swelling |
568 (83.0) 129 (18.9) |
283 (70.4) 48 (11.9) |
<0.001 0.003 |
125 (59.2) 33 (15.6) |
75 (68.8) 12 (11.0) |
0.872 0.142 |
| Bone and muscle pain | 264 (38.6) | 144 (35.8) | 0.362 | 57 (35.5) | 28 (25.6) | 0.418 |
|
Flu like symptoms Fever Headache Chills Sore throat fatigue cough runny nose loss of taste loss of smell |
174(25.4) 248 (36.3) 244 (35.7) 73 (10.7) 381 (55.8) 70 (10.2) 58 (8.5) 12 (1.8) 14 (2.0) |
126 (31.3) 111 (27.6) 107 (26.6) 17 (4.2) 182 (45.3) 21 (5.2) 18 (4.5) 2 (0.5) 2 (0.5) |
0.036 0.003 0.002 <0.001 0.004 0.013 0.076 0.041 |
38(18.0) 45(21.3) 47(22.2) 15(7.1) 85(40.2) 7(3.3) 8 (3.7) 2 (0.9) 3 (1.4) |
19 (17.4) 14(12.8) 22(20.1) 3 (2.7) 36 (33.0) 3(2.7) 6 (5.5) 0 (0.0) 0 (0.0) |
0.554 0.030 0.362 0.071 0.079 0.644 0.649 0.278 0.184 |
|
GI side effect Nausea Diarrhea Vomiting loss of appetite abdominal pain constipation |
127(18.6) 52(7.6) 18(2.6) 74 (11.1) 53 (7.7) 6 (0.9) |
37 (9.2) 18(4.5) 12(3.0) 28 (7.2) 12 (3.0) 1 (0.2) |
<0.001 0.043 0.731 0.039 0.001 0.211 |
16 (7.5) 9(4.2) 7 (3.3) 14(6.6) 4 (1.8) 1 (0.4) |
7 (6.4) 4(3.6) 1 (0.9) 5(4.5) 3 (2.7) 1 (0.9) |
0.509 0.639 0.149 0.330 0.748 0.703 |
|
Psychological SE Sleep disturbance Anxiety and stress Depression |
74 (10.8) 47 (6.9) 35 (5.1) |
36 (9.0) 21 (5.2) 13 (3.2) |
0.326 0.279 0.145 |
17(8.0) 6(2.8) 4(1.8) |
5(4.5) 2(1.8) 1(0.9) |
0.161 0.480 0.430 |
| Irregular menses | 17 (2.5) | 0 (0.0) | 0.001 | 4 (1.8) | 0 (0.0) | 0.125 |
| Decreased libido | 4 (0.6) | 10 (2.5) | 0.007 | 4(1.8) | 1(0.9) | 0.430 |
| Lymph node enlargement & swelling | 8 (1.2) | 4 (1.0) | 0.790 | 2(0.9) | 2 (1.8) | 0.590 |
|
Skin itching Acne Sweating |
26(3.8) 20 (2.9) 45 (6.6) |
3 (0.7) 2 (0.5) 31 (7.7) |
0.003 0.006 0.480 |
5 (2.3) 5 (0.7) 9 (4.2) |
1 (0.9) 0 (0.0) 2 (1.8) |
0.301 0.086 0.193 |
|
Increase urination Change urine color |
9 (1.3) 6 (0.9) |
7 (1.7) 5 (1.2) |
0.574 0.560 |
1 (0.1) 2(0.3) |
1 (0.2) 0 (0.0) |
0.703 0.278 |
| Blurred vision | 30 (4.4) | 10 (2.5) | 0.109 | 8 (1.2) | 0 (0.0) | 0.030 |
|
Cardiac side effects Shortness of breath Palpitation Chest pain Loss of consciousness Paleness Bleeding anywhere |
56 (8.2) 72 (10.5) 39 (5.7) 4 (0.6) 24 (3.5) 4 (0.6) |
20 (5) 21 (5.2) 17 (4.2) 3 (0.7) 11 (2.7) 1 (0.2) |
0.045 0.003 0.289 0.748 0.486 0.430 |
14 (6.6) 6 (2.8) 8 (3.7) 0 (0.0) 5 (0.7) 0 (0.0) |
7 (6.4) 4(3.6) 3(2.7) 0 (0.0) 1 (0.2) 0 (0.0) |
0.724 0.844 0.501 – 0.301 – |
| Dizziness | 119 (17.4) | 38 (9.5) | <0.001 | 20 (9.4) | 7 (6.4) | 0.227 |
| Require hospitalization | 0 (0.0) | 0 (0.0) | 0.260 | 2 (1.0) | 0 (0.0) | 0.241 |
|
Onset of Symptoms Immediately 1st day 1st week 2nd week 3rd week |
69(11.0) 506(80.7) 44 (7.0) 6(1.0) 2(0.3) |
26 (7.9) 275 (83.1) 24 (7.3) 4 (1.2) 2 (0.6) |
0.577 | 20(11.4) 120(68.2) 16(9.1) 19(10.8) 0 (0.0) |
7(6.9) 70(68.6) 5(4.9) 19(18.6) 1(1) |
0.153 |
|
Duration of Symptoms mean (SD) |
2.32(2.3) | 2.64 (4.5) | 0.082 | 2.82 (3.74) | 2.54 (4.1) | 0.354 |
N: population size, SD: standard deviation.